ComplexINC project is launched

ComplexINC addresses the need for sophisticated high-performance platforms for the production of most complex biologics that are distinctly lacking today,  therapeutic proteins are predicted to dominate the next generation of drugs. This project is funded by the EC under FP7 (5,9 Mio €)  and aims to design, validate and roll-out new and powerful tools, high-throughput methods and technologies for the production of complex biologics. This project has an international, intersectoral and innovative consortium combining world-leading expertise at European academic research institutions and successful SMEs. ComplexINC covers the entire domain of eukaryotic production technologies from gene to protein product; in addition, it combines cutting-edge approaches in innovative production system development which are among the most advanced to date. Putting in place the technological innovations and tool-kits obtained in ComplexINC, the research results will have a dramatic impact on the accessibility of proteins, protein complexes and complex biologics. The attained innovations will display tailor-made properties geared towards applications in drug discovery and in the treatment of human diseases, with immediate benefits to industry and the health of Europe’s citizens by cost-effective and powerful new drugs.